Fentolamin | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Fentolamin
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

pharmacompass-1-m-2025-12-22

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

Contact Supplier

pharmacompass-2-m-2025-11-03

Fentolamin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

28 API Suppliers, 7 USDMF, 1 CEP/COS, 1 EU WC, 1 KDMF, 22 NDC API, 6 Listed Suppliers, $ API Reference Price

28 API Suppliers
7 USDMF
1 CEP/COS
1 EU WC
1 KDMF
22 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

44 Drugs in Development

44 Drugs in Development

FINISHED DOSAGE FORMULATIONS

12 FDF Dossiers, 5 FDA Orange Book, 2 Canada, 5 Listed Dossiers

12 FDF Dossiers
5 FDA Orange Book
2 Canada
5 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 2 Kirsch Pharma, 1 BASF, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
1 Gangwal Healthcare
1 Pfanstiehl
2 Kirsch Pharma
1 BASF
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
1 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Taste Masking, 10 Direct Compression, 7 Disintegrants & Superdisintegrants, 6 Parenteral, 3 Co-Processed Excipients, 3 Granulation, 2 Thickeners and Stabilizers, 1 Solubilizers

17 Fillers, Diluents & Binders
12 Chewable & Orodispersible Aids
10 Taste Masking
10 Direct Compression
7 Disintegrants & Superdisintegrants
6 Parenteral
3 Co-Processed Excipients
3 Granulation
2 Thickeners and Stabilizers
1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 27 News #PharmaBuzz

1 Data Compilation #PharmaFlow
27 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

MARKET PLACE

17 APIs, 1 FDF Dossiers

17 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 1 US Exclusivities, 2 Health Canada Patents

9 US Patents
1 US Exclusivities
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

3 EDQM
2 Others

$ API Ref.Price (USD/KG) : 37,543 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

9 All

01 9FAMYGEN LIFE SCI

filter Patent Number Reset all filters

9 All

01 19795560

02 110278918

03 110772829

04 111090261

05 111400077

06 111844858

07 112201615

08 112201616

09 112350366

API Patent Reset all filters

9 All

01 9Blank

filter FDF Patent Reset all filters

9 All

01 6Y

02 3Blank

filter Expiration Date Reset all filters

9 All

01 62034-01-31

02 22039-10-25

03 12039-12-25

Phentolamine Mesylate

Product Main Page

01

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-10-25

PHENTOLAMINE MESYLATE

US Patent Number : 12201616

Drug Substance Claim :

Drug Product Claim :

Application Number : 217064

Patent Use Code : U-3804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-12-25

PHENTOLAMINE MESYLATE

US Patent Number : 12201615

Drug Substance Claim :

Drug Product Claim :

Application Number : 217064

Patent Use Code : U-3804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-12-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-10-25

PHENTOLAMINE MESYLATE

US Patent Number : 11400077

Drug Substance Claim :

Drug Product Claim :

Application Number : 217064

Patent Use Code : U-3804

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 12350366

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 11844858

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 9795560

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 11090261

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 10278918

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

FAMYGEN LIFE SCI

PHENTOLAMINE MESYLATE

BIO Partnering at JPM

Not Confirmed

FAMYGEN LIFE SCI

Country

BIO Partnering at JPM

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-01-31

PHENTOLAMINE MESYLATE

US Patent Number : 10772829

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217064

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-01-31

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.